Related Experiment Video
Updated: Aug 30, 2026

Induction of Nephrotic Syndrome in Mice by Retrobulbar Injection of Doxorubicin and Prevention of Volume Retention by Sustained Release Aprotinin
Published on: May 6, 2018
Intercellular adhesion molecule-1-deficient mice are resistant against renal injury after induction of diabetes
Shinichi Okada1, Kenichi Shikata, Mitsuhiro Matsuda
1Department of Medicine and Clinical Science, Okayama University Graduate School of Medicine and Dentistry, Okayama, Japan.
Abstract:
Diabetic nephropathy is a leading cause of end-stage renal failure. Several mechanisms, including activation of protein kinase C, advanced glycation end products, and overexpression of transforming growth factor (TGF)-beta, are believed to be involved in the pathogenesis of diabetic nephropathy. However, the significance of inflammatory processes in the pathogenesis of diabetic microvascular complications is poorly understood. Accumulation of macrophages and overexpression of leukocyte adhesion molecules and chemokines are prominent in diabetic human kidney tissues. We previously demonstrated that intercellular adhesion molecule (ICAM)-1 mediates macrophage infiltration into the diabetic kidney. In the present study, to investigate the role of ICAM-1 in diabetic nephropathy, we induced diabetes in ICAM-1-deficient (ICAM-1(-/-)) mice and ICAM-1(+/+) mice with streptozotocin and examined the renal pathology over a period of 6 months. The infiltration of macrophages was markedly suppressed in diabetic ICAM-1(-/-) mice compared with that of ICAM-1(+/+) mice. Urinary albumin excretion, glomerular hypertrophy, and mesangial matrix expansion were significantly lower in diabetic ICAM-1(-/-) mice than in diabetic ICAM-1(+/+) mice. Moreover, expressions of TGF-beta and type IV collagen in glomeruli were also suppressed in diabetic ICAM-1(-/-) mice. These results suggest that ICAM-1 is critically involved in the pathogenesis of diabetic nephropathy.
Insights
Intercellular adhesion molecule-1 (ICAM-1) plays a key role in diabetic nephropathy. Blocking ICAM-1 reduces inflammation and kidney damage in diabetic mice, suggesting it
Area of Science:
- Nephrology
- Immunology
- Diabetology
Background:
- Diabetic nephropathy is a major cause of kidney failure.
- Inflammatory processes are implicated in diabetic kidney disease, but their role is not fully understood.
- Intercellular adhesion molecule-1 (ICAM-1) mediates macrophage infiltration in diabetic kidneys.
Purpose of the Study:
- To investigate the role of ICAM-1 in the pathogenesis of diabetic nephropathy.
- To assess the impact of ICAM-1 deficiency on kidney pathology in a mouse model of diabetes.
Main Methods:
- Diabetes was induced in ICAM-1-deficient (ICAM-1(-/-)) and wild-type (ICAM-1(+/+)) mice using streptozotocin.
- Renal pathology was examined over a 6-month period.
- Macrophage infiltration, urinary albumin excretion, glomerular hypertrophy, mesangial matrix expansion, and expression of TGF-beta and type IV collagen were assessed.
Main Results:
- Macrophage infiltration was significantly reduced in diabetic ICAM-1(-/-) mice compared to diabetic ICAM-1(+/+) mice.
- Diabetic ICAM-1(-/-) mice exhibited lower urinary albumin excretion, glomerular hypertrophy, and mesangial matrix expansion.
- Expressions of TGF-beta and type IV collagen were suppressed in the glomeruli of diabetic ICAM-1(-/-) mice.
Conclusions:
- ICAM-1 is critically involved in the pathogenesis of diabetic nephropathy.
- Targeting ICAM-1 may offer a therapeutic strategy for diabetic kidney disease.
